Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_assertion type Assertion NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_head.
- NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_assertion description "[Using flow cytometry (FCM), we have investigated both the DNA content (stained with propidium iodide) and HER-2/neu oncogene expression (revealed by means of an anti-HER-2/neu monoclonal antibody) in neoplastic and non-neoplastic kidney samples from 20 patients with renal cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_provenance.
- NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_assertion evidence source_evidence_literature NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_provenance.
- NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_assertion SIO_000772 1281010 NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_provenance.
- NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_assertion wasDerivedFrom befree-2016 NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_provenance.
- NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_assertion wasGeneratedBy ECO_0000203 NP398289.RAgWIwlevJnn3idbTZlzJYxvFTi8GwHP0YVhkEA1bm_0w130_provenance.